FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

40146211000001101: Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2047751000001112 Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2047761000001110 Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

6 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Has VMP Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags true Inferred relationship Existential restriction modifier
Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Has specific active ingredient Trastuzumab true Inferred relationship Existential restriction modifier
Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Has dispensed dose form Infusion true Inferred relationship Existential restriction modifier
Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Trastuzumab (Trazimera) 176.4mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) 1 bag Is a True Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Inferred relationship Existential restriction modifier
Trastuzumab (Zercepac) 176.4mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) 1 bag Is a True Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Inferred relationship Existential restriction modifier
Trastuzumab (Ontruzant) 176.4mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) 1 bag Is a True Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Inferred relationship Existential restriction modifier
Trastuzumab (Kanjinti) 176.4mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) 1 bag Is a True Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Inferred relationship Existential restriction modifier
Trastuzumab (Herzuma) 176.4mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) 1 bag Is a True Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Inferred relationship Existential restriction modifier
Trastuzumab (Herceptin) 176.4mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) 1 bag Is a True Trastuzumab 176.4mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start